MRS2 and pancreatic neoplasm: Fuc-Hpt concentrations were significantly higher in the pancreatic cancer patients (P < 0.01) and the ELISA had an AUC of 0.91, a sensitivity of 85.1%, and a specificity of 82.3% [129].